Boris A. Kadashev

Boris A. Kadashev

Auto-generated profile, based on publicly available information

Boris A. Kadashev

N. N. Burdenko National Medical Research Center of Neurosurgery, Ministry of Health of Russia

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2020 in Obesity and metabolism
Verified
Journal Article
Open access
PDF file
IKIrina S. Klochkova
Irina S. Klochkova
LALudmila I. Astafyeva
Ludmila I. Astafyeva
BKBoris A. Kadashev
Boris A. Kadashev
YSYuliya G. Sidneva
Yuliya G. Sidneva
PKPavel L. Kalinin
Pavel L. Kalinin
LALuidmila Astafieva
Luidmila Astafieva
The relevance of cachexia syndrome is determined by its high prevalence in clinical practice. It accompanies the course of not only oncological diseases, but also the majority of chronic somatic pathologies, such as chronic heart failure, renal failure, diabetes mellitus, chronic obstructive pulmonary disease, acquired immunodeficiency syndrome, rheumatoid arthritis, Alzheimers disease and others. It is known that even a slight weight loss in patients can determine an unfavorable prognosis of the underlying disease and reduce the effectiveness of therapy, and sometimes it becomes the direct cause of death of the patient. Cachexia is a complex metabolic syndrome, which is based on a violation of the central regulation of metabolism. The dangerous combination of decreased appetite (anorexia) and increased metabolism is the result of an imbalance in energy exchange. Treatment of cachexia syndrome is ineffective and limited in means. Given the progressive and irreversible nature of this syndrome, early diagnosis and prevention of its development are the primary task of the doctor. The article describes the main pathogenetic aspects of the development of cachexia syndrome. They can be common in different diseases. The article discusses the difficulties of diagnosing cachexia syndrome, the possibilities and prospects of treatment.

1 January 2020 in Burdenko's Journal of Neurosurgery
Verified
Journal Article
Closed access
PDF file
МКМ. А. Кутин
М. А. Кутин
BKB.A. Kadashev
B.A. Kadashev
ПКП. Л. Калинин
П. Л. Калинин
DFD.V. Fomichev
D.V. Fomichev
OSO.I. Sharipov
O.I. Sharipov
ИКИ. М. Кутин
И. М. Кутин
When removing the meningiomas of the sellar region, there is always a risk of visual impairment for various reasons, in particular, as a result of traction damage to the optic nerve. Decompression of the optic canal increases nerve mobility during tumor manipulation. In cases of meningioma growing into the canal, its decompression often seems necessary. Evaluation of the effectiveness and risks of performing decompression of the optic canal. The study included patients with meningiomas of the parasellar location, who underwent surgical treatment at the Burdenko Neurosurgical Center for the period from 2001 to 2017. They were divided into two groups - main and control. The main group consisted of 129 patients who underwent decompression of the optic nerve canals when the tumor was removed. The tumor matrix in this group was most often located in the region of the tuberum sellae, supradiaphragmally, in the region of the anterior clinoid process and the optic canal. In 31 cases, decompression was bilateral - during one operation and using one access in 27 patients; in 4 cases, the decompression of the second canal was delayed for 1.5-3 months after the first operation. 160 decompressions were performed by the intradural and 7 - by extradural methods. During intradural decompression, the roof of the optic canal was resected, and during extradural decompression, the lateral wall of the canal was trephined. The control group consisted of 308 patients who did not undergo canal decompression when the tumor was removed. It included meningiomas with a predominant location of the matrix in the area of the tuberclum and diaphragm of the sella. Tumors in both groups were removed according to the same principles (matrix coagulation, mainly the gradual removal of the tumor, the use of ultrasonic aspirator, a situational decision on the radicality of the operation, etc.). The main difference between operations in these two groups was only canal related algorithms (with or without its trepanation), as well as the probable prevalence of significant lateral tumor growth in cases with canal trepanation. Visual functions in the «primary» group were evaluated before and after operations with trepanation of the canal depending on various factors - the initial state of vision and the radicality of the tumor excision, including removal from the canal. The differences in the postoperative dynamics of vision in the main and control groups were studied. The primary data processing was carried out using the program MSExcel. Secondary statistical processing was carried out using the program Statistica. To assess the statistical significance of differences in the results obtained in the compared patient groups, the Chi-square test was used, and in the case of small groups - the exact Fisher test was applied. In the main group postoperative vision improvement of varying degrees on the side of trepanation was registered in 36.9% (59 out of 160) cases, no vision changes were found in 36.9% (59 out of 160), and in 26,2% (42 out of 160) the eyesight deteriorated. If preserving vision is attributed to a satisfactory result, then in general the results of these operations should be considered good. A comparative study of the results of removal of meningiomas with trepanation of the canals (main group) or without it (control group) was carried out among patients with the most critical vision situation (visual acuity 0.1 and below, up to only light perception). These groups are comparable in the number of observations - 62 and 73 respectively. The predominance of cases with improved vision in the main group compared with the control group (50.0% versus 38.36%) and a lower incidence of vision impairment (22.58% versus 34.25%) were found. However, the revealed differences are statistically unreliable and make it possible for us to talk only about the trend. The complications associated with trepanation of the canal include mechanical damage to the nerve by the drill. In our series of observations, there was only 1 case of abrasion of the nerve surface with the burr, which did not lead to a significant visual impairment. With the intradural method of trepanation in the area of the medial wall of the canal, the sphenoid sinus may open (in our series, in 34 cases out of 160 trepanations). Immediately closure of these defects was performed by various auto- and allomaterials in various combinations (pericranium, fascia, muscle fragment, hemostatic materials, and fibrin-thrombin glue). A true complication - CSF rhinorrhea liquorrhea developed in only one case, which required transnasal plastic surgery of the CSF fistula using a mucoperiostal flap. 1. Trepanation of the optic canal in cases of meningiomas of parasellar localization is a relatively safe procedure in the hands of a trained neurosurgeon and does not worsen the results of operations compared with the excision of the same tumors without trepanation of the canal. 2. The literature data and the results of our study make it possible to consider the decompression of the optic canal as an optional, but in many cases, useful option that facilitates the transcranial removal of some meningiomas of the sellar region.

25 December 2017 in Endocrine Surgery
Verified
Journal Article
Open access
PDF file
LALudmila I. Astafyeva
Ludmila I. Astafyeva
BKBoris A. Kadashev
Boris A. Kadashev
PKPavel L. Kalinin
Pavel L. Kalinin
MKMaxim A. Kutin
Maxim A. Kutin
YSYuliya G. Sidneva
Yuliya G. Sidneva
LALuidmila Astafieva
Luidmila Astafieva
Cerebrospinal fluid (CSF) leak is a rare complication in of the prolactinomas treatment with dopamine agonists. In most cases CSF leak develops within the first three months of treatment starting. The article presents a rare clinical case – later development of CSF leak after pharmacological treatment of giant prolactinoma. Women 29 years with giant endo-supra-infra-laterasellar pituitary adenoma (8,7 cm in diameter), visual impairment, cachexia, secondary amenorrhea and prolactin level more than 2 million 200 thousand mU/l treated with cabergoline. On this background, complete regression of the tumor, recovery of visual function, body mass and normalization of prolactin level was marked. Nevertheless, after 6.5 years after beginning of cabergoline therapy CSF leak occured, which required endoscopic endonasal surgery with the plastic of a CSF fistula. All patients with large and giant prolactinomas which invade into skull base structures, receiving cabergoline even for a long time, should be aware of the possibility of such complications as CSF leak and, if necessary, should urgent appeals to the otolaryngologist and the neurosurgeon. In this case closure of skull base defect is a main tactics of treatment.

15 February 2018 in Problems of Endocrinology
Verified
Journal Article
Open access
PDF file
LALudmila I. Astafyeva
Ludmila I. Astafyeva
BKBoris A. Kadashev
Boris A. Kadashev
PKPavel L. Kalinin
Pavel L. Kalinin
MKMaxim A. Kutin
Maxim A. Kutin
IKIrina S. Klochkova
Irina S. Klochkova
LALuidmila Astafieva
Luidmila Astafieva
Background. The pituitary stalk (PS) is an anatomical structure consisting of the portal vessel system and axons of the hypothalamic nuclei terminating in the posterior pituitary lobe. Surgical injury or compression (by a tumor or another space-occupying process) of the PS can lead to hypopituitarism, diabetes insipidus, and hyperprolactinemia. However, the literature lacks studies on the extent of these disorders depending on PS injury or compression in clinical practice. Aim. The study aim was to investigate pre- and postoperative endocrine disorders in patients with chiasmo-sellar region (CSR) tumors and the PS compressed and preserved or involuntarily transected during neurosurgery. Material and methods. The PS compressed before surgery was preserved in 82 patients (41 patients with non-functioning endosuprasellar adenoma and 41 — with suprasellar meningioma). The PS was transected during transcranial surgery in 57 patients (46 patients with pituitary stalk craniopharyngioma and 11 patients with non-functioning endosupresellar pituitary adenoma). All patients underwent blood tests for prolactin (PRL), TSH, LH, FSH, free T4, cortisol, testosterone, or estradiol levels before and 6 months after surgery. Results. Hyperprolactinemia was detected in 37.4% of patients with CSR tumors compressing the PS. Elimination of PS compression led to normalization of the PRL level in most patients and was not accompanied by worsening of hypopituitarism symptoms. Transection of the PS resulted in panhypopituitarism in 100% of patients and diabetes insipidus in 93% of cases. There was no evidence of hyperprolactinemia in 58.7% of patients with craniopharyngiomas and 81.9% of patients with non-functioning pituitary adenomas. Conclusion. Given the difference in symptoms, we distinguished two syndromes: PS compression syndrome and PS transection syndrome. Syndrome of PS compression by a CSR tumor was characterized mainly by hyperprolactinemia (37.4% of cases); elimination of PS compression due to tumor resection led to normalization of the PRL level in most patients and was not accompanied by worsening of hypopituitarism symptoms. Syndrome of surgical PS transection in patients with craniopharyngioma (CP) and non-functioning pituitary adenoma (NFPA) manifested as panhypopituitarism in all patients and as permanent diabetes insipidus in most of them. The causes for the absence of hyperprolactinemia in many patients with the transected PS require further research. We can not exclude both adenohypophysis ischemia (due to its impaired blood supply) with partial or complete atrophy of lactotrophic cells and pituitary revascularization with restoration of dopamine transport.

1 January 2016 in Malignant tumours
Verified
Journal Article
Open access
PDF file
MKM. A. Kutin
M. A. Kutin
DRD. L. Rotin
D. L. Rotin
LSL. V. Shishkina
L. V. Shishkina
LAL. I. Astaf’eva
L. I. Astaf’eva
BKB. A. Kadashev
B. A. Kadashev
ESE. V. Sidoruk
E. V. Sidoruk
Аннотация Авторами статьи установлены морфологические особенности аденом гипофиза, в строму которых происходят кровоизлияния. Исследованы тинкториальные свойства, макро- и микроскопические характеристики. С помощью иммуногистохимического исследования определён уровень экспрессии VEGF, EGFR, циклина D1, белка p53, что позволило предположить непосредственную причину и патогенез питуитарных кровоизлияний.

8 May 2018 in Endocrine Abstracts
Verified
Journal Article
Closed access
LALiudmila Astafyeva
Liudmila Astafyeva
BKBoris Kadashev
Boris Kadashev
PKPavel Kalinin
Pavel Kalinin
MKMaxim Kutin
Maxim Kutin
DFDmitriy Fomichev
Dmitriy Fomichev
LSLiudmila Shishkina
Liudmila Shishkina
Objective: To study the clinical, diagnostic and morphological characteristics and treatment outcomes of TSH-secreting pituitary tumors. Patients and methods: The study included 21 patients with pituitary adenoma and a normal or elevated TSH level and elevated fT4 and fT3 levels who were operated on at the Neurosurgical Institute in the period between 2002 and 2015. Before surgery, in the early postoperative period, and 6 months after surgery, the patients were tested for levels of TSH, fT4, fT3, prolactin, cortisol, LH, FSH, estradiol/testosterone, IGF-1. The thyroid status was evaluated using the following reference values: TSH, 0.4–4.0 mIU/l; fT4, 11.5–22.7 pmol/l; fT3, 3.5–6.5 pmol/l. An immunohistochemical study of material was performed with antibodies to TSH, PRL, GH, ACTH, LH, FSH, and Ki-67 (MiB-1 clone); in 13 cases, we used tests with antibodies to somatostatin receptors type 2 and 5 and to D2 subtype dopamine receptors. Results: TSH-secreting tumors were detected in patients aged from 15 to 67 years (median 39 years), males (48%) and females (52%). Before admission to the Neurosurgical Institute, 11 (52%) patients were erroneously diagnosed with primary hyperthyroidism; seven of these patients underwent surgery on the thyroid gland and/or received thyrostatics (four cases). Hyperthyroidism symptoms were observed in 16 (76%) patients. The level of TSH was 2.47–38.4 mIU/l (median, 6.56); fT4, 22.8–54.8 nmol/l (median, 36); fT3, 4.24–12.9 pmol/l (median, 9.66). Tumors had the sellar localization in 4 (19%) cases and the parasellar localization in 17 (91%) cases. Total tumor resection was performed in 7 (33%) patients. All these tumors had the sellar and suprasellar localization. No total resection was performed in patients with infiltrative growth of adenoma (invading the skull base structures). An immunohistochemically study of tumor resection specimens detected TSH expression in 21 (100%) cases; 18 (86%) tumors were plurihormonal and secreted TSH and GH and/or PRL. Of 13 tumors, expression of the type 2 dopamine receptor was detected in 9 (69%) cases; expression of somatostatin receptors type 5 and type 2 was found in 6 (46%) and 2 (15%) cases, respectively. Conclusion: The criterion for total tumor resection was a postoperative TSH level decrease to 0.1 mIU/l or less. Total resection was performed in 33% of patients with sellar and suprasellar tumors only. In most cases, tumors were plurihormonal secreting TSH and GH and/or PRL.